Stempeutics gets patent for stem cell drug Stempeucel from US Patent and Trademarks Office Medical Dialogues Bureau3 Nov 2019 4:25 AM GMT"The US patent is for the method of treating ischemia by administering pooled allogeneic mesenchymal stromal cells," Stempeutics Research said in a...
Much anticipated Medanta-Manipal deal comes to halt: Report Farhat Nasim20 Aug 2019 8:19 AM GMTMumbai: The much anticipated Medanta-Manipal deal worth Rs 5800 crore has come to a halt. The deal failure is reportedly the result of valuation...